Loading...
Loading...
BNTC| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | -106.0K |
| Gross Profit | 106.0K |
| Operating Expense | 5,980.0K |
| Operating I/L | -5,874.0K |
| Other Income/Expense | -80.0K |
| Interest Income | 0.0K |
| Pretax | -5,954.0K |
| Income Tax Expense | 0.0K |
| Net Income/Loss | -5,954.0K |
Benitec Biopharma Inc. is a biotechnology company specializing in the development of DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. The company's main focus is on developing gene therapy agents such as BB-301 for treating oculopharyngeal muscular dystrophy and BB-103 for chronic hepatitis B virus infection.
